This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Hemorrhage Outcomes Stroke 
DAIC
FEBRUARY 26, 2024
Kulcsar, University Hospital Zurich milla1cf Mon, 02/26/2024 - 12:13 February 26, 2024 — Ischemic strokes are a major health burden. Many stroke patients recover poorly despite timely treatment To treat these symptoms and restore blood flow to the brain, the obstructed vessel needs to be “declogged”, or recanalized.
105 
CardiacWire
JANUARY 24, 2025
Fully published results from Athos Therapeutics AZALEA-TIMI 71 trial for its novel Factor XI inhibitor abelacimab, confirming the drugs lower bleeding risks, but leaving researchers uncertain about its ability to prevent stroke in AFib patients. vs. 0.4%) and 4X ischemic stroke rates (csHR = 4.06). year follow-up. per 100 person-year.
59 
DAIC
MAY 14, 2024
UVA Health's Karen Johnston, MD, the SHINE trial leader, was pleased to see the new insights into best practices for stroke care. These data from the SHINE trial continue to inform the national stroke community about potential approaches to treating hyperglycemic stroke patients to assure better outcomes,” she said.
105 
Stroke Journal
JANUARY 6, 2025
Stroke, Ahead of Print. After 30 years of disappointment, 2 randomized controlled trials investigating the effect of neurosurgical treatment on functional outcome in patients with intracerebral hemorrhage were published in 2024.
75 
Stroke Journal
DECEMBER 16, 2024
Stroke, Ahead of Print. Recovery trajectories in intracerebral hemorrhage (ICH) are recognized as distinct from those observed in ischemic stroke.
75 
DAIC
FEBRUARY 7, 2024
Findings from the highly-anticipated MOST (Multi-Arm Optimization of Stroke Thrombolysis) trial were presented on the first day of the American Stroke Association’s International Stroke Conference, ISC 2024, being held through Feb. The study was looking for improvement in functional outcomes at 90 days. 9 Phoenix, AZ.
105 
CardiacWire
JANUARY 22, 2025
Starting with the good news, GLP-1s lowered risks for 42 health outcomes while increasing risks for 19 outcomes. As expected, GLP-1s reduced MI risk by 9%, cardiac arrest by 22%, incident HF by 11%, ischemic stroke by 7%, and hemorrhagic stroke by 14%. year follow-up.
59 
DAIC
FEBRUARY 8, 2024
Image courtesy: Getty Images christine.book Thu, 02/08/2024 - 15:53 February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association ’s International Stroke Conference , ISC 2024 , shed light on the use of artificial intelligence ( AI ) to help guide treatment decisions for stroke patients.
105 
DAIC
FEBRUARY 9, 2024
announced the primary endpoint results of its EvaQ Trial , a prospective, multi-center, global, single arm, FDA-regulated IDE trial study to evaluate the safety and effectiveness of the MIVI Q Revascularization System for treating acute ischemic stroke. milla1cf Fri, 02/09/2024 - 09:28 February 9, 2024 — MIVI Neuroscience, Inc. mTICI 2b/3.
105 
Journal of the American Heart Association
DECEMBER 18, 2023
BackgroundIntravenous thrombolysis (IVT) is an effective stroke therapy that remains underused. In this study we aim to investigate the safety and efficacy of IVT in patients with acute ischemic stroke and recent DOAC use.Methods and ResultsA systematic review and meta‐analysis of proportions evaluating IVT with recent DOAC use was conducted.
75 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP164-AWP164, February 1, 2024. Introduction:Patients who have had hemorrhagic strokes experience psychological and functional deficits after hospital discharge. Social Determinants of Health (SDoH) can also impact outcomes.
40 
Stroke Journal
JANUARY 26, 2025
Stroke, Volume 56, Issue 2 , Page 285-293, February 1, 2025. BACKGROUND:Sex-specific differences in stroke risk factors, clinical presentation, and outcomes are well documented. Primary end points were 90-day readmission for ischemic stroke or hemorrhage and compared between men and women.
40 
Stroke Journal
DECEMBER 21, 2023
Stroke, Volume 55, Issue 1 , Page 50-58, January 1, 2024. BACKGROUND:The effect of marine omega-3 PUFAs on risk of stroke remains unclear.METHODS:We investigated the associations between circulating and tissue omega-3 PUFA levels and incident stroke (total, ischemic, and hemorrhagic) in 29 international prospective cohorts.
74 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page A125-A125, February 1, 2025. Introduction:Managing post-acute hemorrhagic stroke care is complex and necessitates close follow-up and coordination. Ninety-day modified Rankin Scale (mRS) evaluated functional outcomes analyzed using a proportional odds logistic regression.
40 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ADP8-ADP8, February 1, 2025. the 2023 calendar year, our comprehensive stroke metric for hemorrhagic stroke scoring was at 64%, below the 'Get with the Guidelines' benchmark of 87%.To We continue to assess compliance and project feasibility.We
40 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP230-AWP230, February 1, 2025. Hemorrhagic strokes (HS) are increasingly significant causes of disability and mortality worldwide, making the use of blood biomarkers for their diagnosis and prognosis critical. Survivors had GFAP levels of 1.35
40 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP236-AWP236, February 1, 2025. Background:A novel inflammatory score has been validated for hematoma expansion and poor outcomes in patients with intracerebral hemorrhage. Inflammatory score was significantly higher in patients with hemorrhagic transformation.
40 Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP199-ATP199, February 1, 2025. Introduction:Intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) are severe forms of stroke with high morbidity and mortality rates. These findings highlight the potential neuroprotective role of statins in hemorrhagic stroke.
40 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATMP81-ATMP81, February 1, 2024. Background and Purpose:Post thrombolytic intracerebral hemorrhage (ICH) is associated with higher rate of death or disability in acute ischemic stroke patients. Outcomes were determined by using utility weighted modified Rankin scale (UW-mRs) at 90-days.
40 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP170-ATP170, February 1, 2025. In stroke, it has been associated with infarct growth, hemorrhagic transformation, and poor outcomes. WMD burden was assessed using Fazekas scoring on post-stroke T2 FLAIR sequences by three raters.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP279-ATP279, February 1, 2024. Whether atrial cardiopathy is associated with the risk of intracranial hemorrhage in acute ischemic stroke (AIS) remains uncertain. Our primary outcomes included any intracranial hemorrhage (ICH) and symptomatic ICH (sICH) during follow-up.
40 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATMP18-ATMP18, February 1, 2025. Background and Issues:Timely identification and intervention are critical for positive outcomes in acute intracerebral hemorrhage (ICH) patients. Conclusions:Having measurable goals for ICH has demonstrated a significant improvement in outcomes.
40 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWMP81-AWMP81, February 1, 2024. Introduction:Intracerebral Hemorrhage (ICH) leads to high rates of morbidity and mortality. Malnutrition is common in stroke patients and leads to worse outcomes. 7.34) and lobar (OR 3.15, 95% CI 1.67-5.94) 5.94) groups. Albumin (OR 2.27, 95% CI 1.05-4.90)
40 Stroke Journal
FEBRUARY 27, 2024
Stroke, Ahead of Print. The primary outcome was functional status measured by the modified Rankin Scale at 90 to 180 days. Earlier SBP control was associated with better functional outcomes (modified Rankin Scale score, 3–6; odds ratio, 0.98 [95% CI, 0.97–0.99]) SD, 13.0], 2120 [36.8%] females) were included in analyses.
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP190-ATP190, February 1, 2025. Background:The prognostic significance of the affected hemisphere in hemorrhagic stroke remains uncertain. The association of ICH laterality with clinical outcomes was estimated using multiple linear regression models.
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWMP78-AWMP78, February 1, 2024. Introduction:Mobile stroke units (MSUs) are an evolving means to expedited acute stroke management. Faster time metrics convey a hypothetical benefit towards improved patient outcomes. The target blood pressure goal was met much quicker in the MSU.
40 Stroke Journal
DECEMBER 15, 2023
Stroke, Ahead of Print. Intracerebral hemorrhage is the most serious type of stroke, leading to high rates of severe disability and mortality. Hematoma expansion is an independent predictor of poor functional outcome and is a compelling target for intervention.
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP168-ATP168, February 1, 2024. Objective:Disorders of consciousness (DoC) are known to correlate with worse functional outcome after hemorrhagic stroke. The primary outcome was coma (GCS ≤ 8) at time of admission. The median [IQR] ICH volume was 9.3
40 Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWMP80-AWMP80, February 1, 2025. Introduction:Stroke is a devastating complication of infective endocarditis (IE) and is associated with poor outcomes. Out of 526 cases, 511 had active infection and were screened for acute stroke associated with IE.
40 
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP155-AWP155, February 1, 2025. Background:Cancer-related stroke (CRS) is a rare condition where a tumor or its metastasis can compress a blood vessel and result in stroke. Patients were divided into those with strokes (ischemic or hemorrhagic) and those without strokes.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP19-ATP19, February 1, 2024. Background:Studies describing outcomes of subarachnoid hemorrhage (SAH) in children are sparse. 1.02], p<0.001), higher NIS-Subarachnoid Hemorrhage Severity Score (NIS-SSS) (12.64 [4.21-37.95], The median age was 11.8 years (95% CI, 11.0-12.5),
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP34-ATP34, February 1, 2024. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. years with 72,650 (61.0%) being female.
40 
Journal of the American Heart Association
JANUARY 23, 2025
We aimed to investigate the prevalence and prognostic implications of AMI in primary intracerebral hemorrhage.Methods and ResultsWe retrospectively analyzed patients with primary intracerebral hemorrhage within 48 hours after symptom onset. Patients were followed for up to 5 years. Of 600 patients included, 115 had AMI (19.2%).
40 Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWMP79-AWMP79, February 1, 2025. Background and Purpose:The inflammatory response after ischemic and hemorrhagic stroke is associated with worse clinical outcomes through immune mediated production of pro- inflammatory cytokines.
40 Stroke: Vascular and Interventional Neurology
FEBRUARY 9, 2024
Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDThrombectomy is well‐established management for acute ischemic stroke involving large vessel occlusion. The primary outcome was good functional outcome at 3 months. The odds ratio (OR) of good functional outcome at 3 months was 0.93 (95% CI, 0.68–1.28)
75 Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP205-ATP205, February 1, 2025. Introduction:Alzheimers Disease (AD), characterized by extracellular deposition of amyloid beta (A) plaques in brain tissue, is often comorbid with cerebral amyloid angiopathy, which carries an elevated risk of intracranial hemorrhage. andICD-10-CMcode G30.x.
40 Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page AWP177-AWP177, February 1, 2024. Clinical characteristics, technical considerations associated with thrombectomy, severity and subtypes of HT (Heidelberg) and clinical outcomes were analyzed.Results:HT was adjudicated present in 70 out of 149 (47.0%) consecutive thrombectomy patients.
40 Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP228-AWP228, February 1, 2025. Introduction:Intracerebral hemorrhage (ICH) volume and expansion are important predictors of clinical outcome. Recent results show volumetric thresholds for prediction of poor outcome differ based on the anatomic location (lobar vs deep) of the ICH.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page A2-A2, February 1, 2024. Background:Mobile stroke units (MSUs) improve outcomes in thrombolytic-eligible ischemic stroke patients. Higher mortality was noted after 5 days post-ictus in the MSU group (26.5% vs. 14.1%, p = 0.04).Conclusion:In
40 Journal of the American Heart Association
DECEMBER 14, 2024
This study aimed to assess whether statin use could lead to better outcomes among individuals with AF.Methods and ResultsWe enrolled 397 787 patients with AF from January 1, 2012 to December 31, 2020. We analyzed 288 958 patients with newly diagnosed AF (mean age, 73 years; 44% women; mean CHA2DS2VASc score, 3.5).
Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page AWP51-AWP51, February 1, 2025. The exposure was an incident diagnosis of non-traumatic intracranial hemorrhage, defined as a composite of intracerebral hemorrhage, subarachnoid hemorrhage, or subdural hemorrhage. The outcome was an incident diagnosis of dementia.
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page ATP244-ATP244, February 1, 2024. Racial and ethnic disparities in risk factors and outcomes for young patients with ischemic stroke (AIS) are well described. All tests were two-tailed and the error rate was set at 5%.Results:Among Results:Among 430 patients who met inclusion criteria, 22.3%
40 
Stroke Journal
FEBRUARY 1, 2024
Stroke, Volume 55, Issue Suppl_1 , Page A59-A59, February 1, 2024. Introduction:Many patients are taking antiplatelet medications when an acute stroke occurs. The exposure of interest was pre-stroke antiplatelet use categorized as none, single (SAPT), and dual antiplatelet therapy (DAPT). no antiplatelet, 36.7% SAPT, and 6.4%
40 Stroke Journal
JANUARY 30, 2025
Stroke, Volume 56, Issue Suppl_1 , Page ATP343-ATP343, February 1, 2025. Background:Subarachnoid Hemorrhage (SAH) accounts for 2-7% of strokes and has high mortality and morbidity. The identified genes and networks may guide the search for potential biomarkers of outcome and novel treatment targets.
40
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content